Vanguard Group’s UpHealth, Inc. UPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-289,352
Closed -$284K 4596
2023
Q3
$284K Sell
289,352
-3,326
-1% -$4.86K ﹤0.01% 4194
2023
Q2
$550K Buy
292,678
+3,796
+1% +$6.28K ﹤0.01% 4092
2023
Q1
$430K Buy
288,882
+16,612
+6% +$36.7K ﹤0.01% 4164
2022
Q4
$444K Buy
272,270
+107
+0% +$416 ﹤0.01% 4128
2022
Q3
$1.45M Buy
272,163
+5,313
+2% +$31.8K ﹤0.01% 3871
2022
Q2
$1.58M Hold
266,850
﹤0.01% 3911
2022
Q1
$3.15M Buy
266,850
+15,804
+6% +$350K ﹤0.01% 3760
2021
Q4
$5.62M Buy
+251,046
New +$5.81M ﹤0.01% 3540

Other funds holding UPH

Vanguard Group's UPH Position: Q4 2023 in Review

Vanguard Group sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 289,352 shares — an estimated $284K sold.

Vanguard Group first reported a position in UPH in Q4 2021 and held it in 8 quarters. The position peaked at $5.62M in Q4 2021. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • Vanguard Group reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • Vanguard Group sold 289,352 UpHealth, Inc. shares in Q4 2023, an estimated $284K.
  • Vanguard Group first reported a position in UpHealth, Inc. in Q4 2021 and held it in 8 quarters.
  • Vanguard Group's UpHealth, Inc. position peaked at $5.62M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.